A detailed history of Lokken Investment Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Lokken Investment Group LLC holds 4,036 shares of AMGN stock, worth $1.19 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
4,036
Previous 3,742 7.86%
Holding current value
$1.19 Million
Previous $1.17 Million 11.21%
% of portfolio
0.57%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $90,957 - $99,189
294 Added 7.86%
4,036 $1.3 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $117,974 - $143,370
449 Added 13.63%
3,742 $1.17 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $47,858 - $57,771
178 Added 5.71%
3,293 $936,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $551,800 - $622,496
2,158 Added 225.5%
3,115 $897,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $209,248 - $259,787
957 New
957 $257,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lokken Investment Group LLC Portfolio

Follow Lokken Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lokken Investment Group LLC with notifications on news.